Literature DB >> 8216881

Lead/ethanol interactions. II: pharmacokinetics.

J R Nation1, R T Burkey, C A Grover.   

Abstract

Adult male rats were exposed ad libitum to water containing either 500 ppm lead acetate (group-lead) or an equivalent amount of sodium acetate (group-control) for 60 days prior to receiving ip injections of either 1.0, 2.0, or 3.0 g/kg ethanol (20% v/v). Blood alcohol concentrations (BACs) were recorded over a 6-h time period postinjection, and the groups were compared at each dose for differences in the pattern of ethanol pharmacokinetics. While there was a dose-related effect obtained with increasing ethanol doses producing increasing BAC values, at no dose was there any evidence of group separation at any point during the 6-h postinjection period. These data are instructive with respect to understanding the nature of previously demonstrated lead/ethanol interactions, and rule out the possibility that lead-induced disturbances in the catalysis of ethanol, or some other pharmacokinetic operation, is the basis for the effects of lead on ethanol intake and ethanol administration. Alternative possible accounts of this curious interaction between a xenobiotic contaminant and alcohol are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216881     DOI: 10.1016/0741-8329(93)90021-f

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  7 in total

1.  Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.

Authors:  Ryan Himes; Frederick H Wezeman; John J Callaci
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

2.  Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone.

Authors:  John J Callaci; Dainius Juknelis; Avinash Patwardhan; Frederick H Wezeman
Journal:  Alcohol Clin Exp Res       Date:  2006-04       Impact factor: 3.455

3.  Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol.

Authors:  John J Callaci; Ryan Himes; Kristen Lauing; Phillip Roper
Journal:  Alcohol Alcohol       Date:  2010-06-16       Impact factor: 2.826

4.  Binge alcohol treatment of adolescent rats followed by alcohol abstinence is associated with site-specific differences in bone loss and incomplete recovery of bone mass and strength.

Authors:  Kristen Lauing; Ryan Himes; Matthew Rachwalski; Patrick Strotman; John J Callaci
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

5.  The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.

Authors:  John J Callaci; Dainius Juknelis; Avinash Patwardhan; Mark Sartori; Nathan Frost; Frederick H Wezeman
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

6.  Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.

Authors:  Frederick H Wezeman; Dainius Juknelis; Ryan Himes; John J Callaci
Journal:  Bone       Date:  2007-06-15       Impact factor: 4.398

7.  Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone.

Authors:  John J Callaci; Ryan Himes; Kristen Lauing; Frederick H Wezeman; Kirstyn Brownson
Journal:  Calcif Tissue Int       Date:  2009-03-28       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.